| Value | ₹0.36 Cr |
|---|
BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹42.52
- Market cap
- ₹73.57 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 8.2×Sector 45.9×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C
Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.
- Value
- ₹0.22 Cr
- From
- First Vet Veterinary Medicines Trading L.L.C
- Execution
- Within the mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹0.1 Cr Order from Genet International
Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.
- Value
- ₹0.10 Cr
- From
- Genet International
- Execution
- Within mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.
Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.
- Value
- ₹3.15 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.
- Execution
- Within mutually agreed timelines as per purchase order schedule
Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...
Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.
- Value
- ₹3.47 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
- Execution
- As per mutually agreed purchase order schedules
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.
Shelter Pharma Preferential Issue
Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.
- Value
- ₹1.96 Cr
Other capital structure change announcements
All →First Fintec Capital Structure Change
Vipin Vishvanath Agarwal acquired 8,32,220 First Fintec shares, about 8%, off-market. As a non-promoter, this SAST disclosure records a listed-equity stake change.
PC Jeweller Capital Structure Change
UNICO Global Opportunities Fund, a non-promoter, sold 13.86 crore PC Jeweller shares in market sales from July to October 2026. Its stake fell from 4.97% to 2.97%.
Piramal Pharma Capital Structure Change
HDFC Mutual Fund schemes reduced their Piramal Pharma stake by 2.027% via open market sale on 28 October 2026. Holding fell from 7.015% to 4.988%.
Rane Holdings Capital Structure Change
Rane Holdings took up 5,15,954 rights shares in its 49%-owned JV, ZF LIFETEC Rane Automotive. No consideration is disclosed, and its stake stays at 49%.
Automobile Corporation Of Goa Capital Structure Change
Automobile Corporation of Goa filed its buyback letter of offer for 1,44,639 shares at Rs 2,005 each. Up to Rs 29.00 Crore tender buyback opens November 3.
- Value
- ₹29.00 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
- Value
- ₹69.70 Cr
- Execution
- August 14, 2026 to October 30, 2026